Peripheral neuropathy: Differential diagnosis and management

American Family Physician

Volumn 81, Issue 7, 2010, Pages 887-892

  Azhary, Hend ^a   Farooq, Muhammad U ^a   Bhanushali, Minal ^a   Majid, Arshad ^a   Kassab, Mounzer Y ^a  

^a MICHIGAN STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYANOCOBALAMIN; GLUCOSE; THYROTROPIN;

ANAMNESIS; ARTICLE; BLOOD CELL COUNT; BLOOD CHEMISTRY; CEREBROSPINAL FLUID ANALYSIS; CHRONIC INFLAMMATORY DEMYELINATING POLYNEUROPATHY; DIABETES MELLITUS; DIFFERENTIAL DIAGNOSIS; DRUG INDUCED DISEASE; ELECTRODIAGNOSIS; ELECTROMYOGRAPHY; ERYTHROCYTE SEDIMENTATION RATE; GLUCOSE BLOOD LEVEL; GUILLAIN BARRE SYNDROME; HUMAN; HYPOTHYROIDISM; LUMBAR PUNCTURE; NERVE BIOPSY; NUTRITIONAL DEFICIENCY; PERIPHERAL NEUROPATHY; PHYSICAL EXAMINATION; PREVALENCE; THYROTROPIN BLOOD LEVEL; ALGORITHM; MALNUTRITION; METHODOLOGY;

ALGORITHMS; DIABETES COMPLICATIONS; ELECTROMYOGRAPHY; HUMANS; HYPOTHYROIDISM; MALNUTRITION; PERIPHERAL NERVOUS SYSTEM DISEASES; PHYSICAL EXAMINATION;

EID: 77952302061     PISSN: 0002838X     EISSN: 0002838X     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. Martyn CN, Hughes RA. Epidemiology of peripheral neuropathy J Neurol Neurosurg Psychiatry. 1997;62(4):310-318.
2. Hughes RA. Peripheral neuropathy. BMJ. 2002;324(7335):466-469. (Pubitemid 34169466)
3. Davies M, Brophy S, Williams R, Taylor A. The prevalence, severity, and impact of painful diabetic peripheral neuropathy in type 2 diabetes. Diabetes Care. 2006;29(7):1518-1522. (Pubitemid 44127574)
4. England JD, Gronseth GS, Franklin G, et al., for the American Academy of Neurology, American Association of Electrodiagnostic Medicine, American Academy of Physical Medicine and Rehabilitation. Distal symmetric polyneuropathy a definition for clinical research. Neurology. 2005;64(2):199-207.
5. Willison HJ, Winer JB. Clinical evaluation and investigation of neuropathy. J Neurol Neurosurg Psychiatry. 2003;74(suppl 2):ii3-ii8.
6. Winer JB. Guillain-Barré syndrome. BMJ. 2008;337:a671.
7. Dyck PJ, Lais AC, Ohta M, Bastron JA, Okazaki H, Groover RV. Chronic inflammatory polyradiculoneuropathy Mayo Clin Proc. 1975;50(11):621-637.
8. Lewis RA. Chronic inflammatory demyelinating polyneuropathy Neurol Clin. 2007;25(1):71-87.
9. Hughes RA, Raphaël JC, Swan AV, van Doom PA. Intravenous immunoglobulin for Guillain-Barré syndrome. Cochrane Database Syst Rev. 2001; (2):CD002063.
10. Raphaël JC, Chevret S, Hughes RA, Annane D. Plasma exchange for Guillain-Barré syndrome. Cochrane Database Syst Rev 2001;(2):CD001798.
11. Lawn ND, Fletcher DD, Henderson RD, Wolter TD, Wijdicks EF. Anticipating mechanical ventilation in Guillain-Barré syndrome. Arch Neurol. 2001;58(6):893-898. (Pubitemid 32537463)
12. McCarberg BH, Billington R. Consequences of neuropathic pain: quality-of-life issues and associated costs. Am J Manag Care. 2006;12(9 suppl): S263-S268. (Pubitemid 43993104)
13. McQuay H, Carroll D, Jadad AR, Wiffen P, Moore A. Anticonvulsant drugs for management of pain: a systematic review. BMJ. 1995;311 (7012):1047-1052.
14. Rull JA, Quibrera R, González-Millán H, Lozano Castañeda O. Symptomatic treatment of peripheral diabetic neuropathy with carbamazepine (Tegretol): double blind crossover trial. Diabetologia. 1969;5(4):215-218.
15. Ollat H, Cesaro P. Pharmacology of neuropathic pain. Clin Neuropharmacol. 1995;18(5):391-404.
16. Sindrup SH, Jensen TS. Pharmacologic treatment of pain in polyneuropathy Neurology. 2000;55(7):915-920.
17. Woolf CJ, Mannion RJ Neuropathic pain: aetiology, symptoms, mechanisms, and management. Lancet. 1999;353(9168):1959-1964.
18. Mendell JR, Sahenk Z. Clinical practice. Painful sensory neuropathy. N Engl J Med. 2003;348(13):1243-1255. (Pubitemid 36359301)
19. Sindrup SH, Jensen TS. Efficacy of pharmacological treatments of neuropathic pain: an update and effect related to mechanism of drug action. Pain. 1999;83(3):389-400.